Ken Griffin acquired 2.35 Million Janux Therapeutics shares worth $118 Million. That's 0.12% of their equity portfolio (185th largest holding). The investor owns 5.04% of the outstanding Janux Therapeutics stock. The first Janux Therapeutics trade was made in Q2 2021. Since then Ken Griffin bought shares three more times and sold shares on six occasions. The stake costed the investor $41.2 Million, netting the investor a gain of 188% so far.